Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Humoral Rejection After Kidney Transplantation”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Testing effectiveness (Phase 2)Ended earlyNCT00568477
What this trial is testing

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation

Who this might be right for
GraftingRenal TransplantationTransplantation, Kidney+1 more
Technical University of Munich 200
Large-scale testing (Phase 3)Study completedNCT01350882
What this trial is testing

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation

Who this might be right for
Humoral Rejection in Kidney Transplantation
University Hospital, Tours 40
Large-scale testing (Phase 3)UnknownNCT01066689
What this trial is testing

Impact of Treatment With Rituximab on the Progression of Humoral Acute Rejection After Renal Transplantation

Who this might be right for
Graft Rejection
University Hospital, Tours 64
Testing effectiveness (Phase 2)Ended earlyNCT01895127
What this trial is testing

Efficacy and Safety of Eculizumab for Treatment of Antibody-mediated Rejection Following Renal Transplantation

Who this might be right for
Antibody-mediated RejectionHumoral Rejection
Brigham and Women's Hospital 11
Not applicableNot Yet RecruitingNCT05890430
What this trial is testing

Study of Alloimmune Response in Humoral Rejection After Kidney Transplantation

Who this might be right for
Kidney TransplantationKidney Allograft BiopsyHumoral Rejection+1 more
University Hospital, Strasbourg, France 570
Not applicableEnded earlyNCT02095821
What this trial is testing

Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange

Who this might be right for
Clotting Disorder Due to Plasma Exchange TherapyHumoral Rejection After Kidney Transplantation
Hannover Medical School 2